JasonVBakerMDMS
Infectious Disease • Minneapolis, MNHIV/AIDS Medicine
Director of Infectious Disease, Hennepin Healthcare | Professor of Medicine, University of Minnesota
Dr. Baker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
701 Park Ave
Mail Code G5
Minneapolis, MN 55415Phone+1 612-873-2700Fax+1 612-904-4440
Summary
- Dr. Jason Baker is an infectious disease specialist in Minneapolis, MN and is affiliated with Hennepin Healthcare. He received his medical degree from University of Wisconsin School of Medicine and Public Health and has been in practice 16 years. He specializes in hiv/aids medicine and is experienced in cardiac manifestations of hiv infection, hiv/aids, and covid-19.
Education & Training
University of MinnesotaFellowship, Infectious Disease, 2004 - 2007
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2001 - 2004
University of Wisconsin School of Medicine & Public HealthClass of 2001
Certifications & Licensure
OR State Medical License 2003 - Present
MN State Medical License 2005 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- Aspirin and Antiretroviral Therapy in HIV Infected Patients Start of enrollment: 2008 Oct 01
- Cardiovascular Prevention for Persons With HIV Start of enrollment: 2009 Sep 01
- Artery Elasticity After Switch From Epzicom to Truvada Start of enrollment: 2009 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsElevated N-terminal prohormone of brain natriuretic peptide among persons living with HIV in a South African peri-urban townshipTess E Peterson, Jason V. Baker, Lye-Yeng Wong, Adam Rupert, Ntobeko A B Ntusi
ESC Heart Failure. 2020-10-01 - 279 citationsA Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.J D Lundgren, Birgit Grund, Christina E. Barkauskas, Thomas L. Holland, Robert L. Gottlieb
The New England Journal of Medicine. 2021-03-11 - 1 citationsEffect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.Tomas O Jensen, Greg A Grandits, Mamta K Jain, Thomas A Murray, Birgit Grund
The Journal of Infectious Diseases. 2024-03-14
Press Mentions
NIH Study Evaluating Shionogi Antiviral in Hospitalized People with COVID-19February 15th, 2023- NIH Trial to Evaluate Shionogi Antiviral in Adults Hospitalized with COVID-19February 15th, 2023
- A National Institutes of Health Trial Evaluating Shionogi Interferon in Adults Hospitalized with COVID-19February 15th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
